Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
Condition(s):Autoimmune Pulmonary Alveolar ProteinosisLast Updated:September 17, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Autoimmune Pulmonary Alveolar ProteinosisLast Updated:September 17, 2014Unknown status
Condition(s):HIV Infections; CytopeniasLast Updated:November 4, 2021Completed
Condition(s):NeuroblastomaLast Updated:January 5, 2024Active, not recruiting
Condition(s):Malignant MelanomaLast Updated:July 11, 2006Completed
Condition(s):Sarcoma, Kaposi; HIV InfectionsLast Updated:November 2, 2021Completed
Condition(s):Cytomegalovirus Retinitis; HIV InfectionsLast Updated:November 4, 2021Completed
Condition(s):Prostate CancerLast Updated:March 28, 2019Completed
Condition(s):LeukemiaLast Updated:January 19, 2017Completed
Condition(s):Transplant-Related Hematologic MalignancyLast Updated:November 8, 2023Recruiting
Condition(s):HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast CancerLast Updated:February 10, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.